Burgard E C, Cote T E, Sarvey J M
Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799.
Neuroscience. 1993 May;54(2):377-89. doi: 10.1016/0306-4522(93)90259-i.
Bath application of the muscarinic receptor agonist, muscarine, produced a concentration-dependent depression of synaptic activity in the dentate gyrus of hippocampal slices. A concentration of 10 microM muscarine produced a reversible depression that could be competitively antagonized by the muscarinic receptor antagonist pirenzepine. However, other muscarinic receptor subtype (M1-M3) antagonists could also block the effects of muscarine. The rank order of antagonist potency was: 4-diphenylacetoxy-N-methyl-piperidine methiodide (M3/M1 antagonist) > pirenzepine (M1) > AFDX-116 (M2). The depression produced by 10 microM muscarine was not affected by in vivo pretreatment with pertussis toxin, and therefore was not mediated by a pertussis toxin-sensitive G-protein. In addition, high concentrations of muscarine did not affect either basal or isoproterenol-stimulated accumulation of cyclic AMP from slices of dentate gyrus. Muscarine also produced a concentration-dependent blockade of the induction of norepinephrine-induced long-lasting potentiation in the dentate gyrus. Norepinephrine-induced long-lasting potentiation is a form of long-lasting plasticity induced in medial perforant path synapses by beta-adrenergic agonists such as isoproterenol. The muscarinic blockade of norepinephrine-induced long-lasting potentiation was also prevented by pretreatment with pirenzepine. Based on these pharmacological data, we conclude that muscarinic depression of evoked responses, as well as blockade of norepinephrine-induced long-lasting potentiation, involves activation of either M3 or M1, but not M2, muscarinic receptors. These data also demonstrate that in addition to modulating normal synaptic transmission, muscarinic receptors may also play an important role in modulating synaptic plasticity.
在海马切片齿状回中,通过浴槽给药毒蕈碱型受体激动剂毒蕈碱,可产生浓度依赖性的突触活动抑制。10微摩尔毒蕈碱的浓度产生可逆性抑制,可被毒蕈碱型受体拮抗剂哌仑西平竞争性拮抗。然而,其他毒蕈碱型受体亚型(M1 - M3)拮抗剂也可阻断毒蕈碱的作用。拮抗剂效力的顺序为:4 - 二苯基乙酰氧基 - N - 甲基 - 哌啶甲碘化物(M3/M1拮抗剂)>哌仑西平(M1)>AFDX - 116(M2)。10微摩尔毒蕈碱产生的抑制不受百日咳毒素体内预处理的影响,因此不是由百日咳毒素敏感的G蛋白介导的。此外,高浓度的毒蕈碱对齿状回切片中环磷酸腺苷的基础积累或异丙肾上腺素刺激的积累均无影响。毒蕈碱还产生浓度依赖性地阻断去甲肾上腺素诱导的齿状回长时程增强。去甲肾上腺素诱导的长时程增强是由β - 肾上腺素能激动剂如异丙肾上腺素在内侧穿通路径突触中诱导的一种长时程可塑性形式。哌仑西平预处理也可预防毒蕈碱对去甲肾上腺素诱导的长时程增强的阻断。基于这些药理学数据,我们得出结论,毒蕈碱对诱发反应的抑制以及对去甲肾上腺素诱导的长时程增强的阻断涉及M3或M1而非M2毒蕈碱型受体的激活。这些数据还表明,除了调节正常的突触传递外,毒蕈碱型受体在调节突触可塑性方面可能也发挥重要作用。